Pramipexole Conversion to Ropinirole Controlled Release (CR)

NCT00275275 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Requip PR
DRUG: Mirapex

Sponsor

Rajesh Pahwa, MD

Collaborators

[object Object]